At the completion of this CME teaching activity, you should be able to:

• Discuss the most useful diagnostic features in distinguishing amongst the various well-differentiated lipomatous tumors.
• Explain the approach to mesenchymal tumors of the gastrointestinal tract based upon primary cytology of the neoplastic cells.
• Discuss the most common diagnostic entities in the differential diagnosis of highly cellular spindle cell tumors.
• Describe the WHO criteria for the diagnosis of lobular carcinoma in situ and the uses and limitations of e-cadherin immunohistochemistry in evaluating in-situ lesions of the breast.
• Summarize the recent updates in the molecular basis of thyroid neoplasia as well as to understand the historical and practical reasons for the complexity of tumor characterization.
• Use the differentia diagnosis of chronic idiopathic inflammatory bowel disease and its mimics in daily practice.
• Discuss the practical approach to the diagnosis of papillary lesions of the breast aided by a targeted panel of immunohistochemical markers.
• Review relevant updates in prostate cancer grading and unfavorable pathologic features and their impact on reporting.
• Discuss common and uncommon renal tumors with eosinophilic cytoplasm and become familiar with key morphologic and immunohistochemical features useful in making these distinctions.
• Recognize the morphologic correlation of cytopathologic findings with histopathologic features and discuss the utility of ancillary molecular testing for the diagnosis of salivary gland lesions.
• Describe current testing guidelines with an optimized approach for histologic and cytologic samples of suspected HPV-related squamous cell carcinoma.
• Use a basic framework of histologic patterns and their clinical and laboratory correlates to diagnose common medical liver diseases.
• Apply diagnostic criteria for common inflammatory neoplastic diseases of the appendix in daily practice.
• Characterize the common elements of neuroendocrine neoplasia throughout the body.
• Summarize the spectrum of steroidogenic tissues and understand their structural and functional features.
• Discuss the difficulties in evaluating breast lumpectomy and mastectomy specimens following neoadjuvant chemotherapy.
• Describe the histologic features and clinical significance of the spectrum of myoepithelial and combined epithelial-myoepithelial lesions of the breast.

Program :

An Approach to Well-Differentiated Lipomatous Tumors
John R. Goldblum, M.D.

Papillary Lesions of the Breast
Carmen Gomez-Fernandez, M.D.

Biopsy Evaluation of Non-Neoplastic Diseases of the Large Bowel: An Algorithmic Approach
Laura W. Lamps, M.D.

Thyroid Neoplasia: Inching Towards a Molecular Classification
Sylvia L. Asa, M.D., Ph.D.

Spindle Cell Tumors with a Focus on Use of Ancillary Diagnostic Techniques
John R. Goldblum, M.D.

Lobular Carcinoma In-Situ and Problematic In-Situ Breast Lesions
Stuart J. Schnitt, M.D.

Salivary Gland Pathology: The Complementary Roles of Cytopathology and Histopathology and the Emergency of Molecular Diagnostics
Carmen Gomez-Fernandez, M.D.

Medical Liver Disease: A Basics Refresher Course
Laura W. Lamps, M.D.

Prostate Cancer 2022
Cristina Magi-Galluzzi, M.D., Ph.D.

Neuroendocrine Tumors: Hormones from Head to Tail
Sylvia L. Asa, M.D., Ph.D.

The Challenge of Evaluating Post-Neoadjuvant Systemic Therapy Breast Specimens
Stuart J. Schnitt, M.D.

Beyond Acute Appendicitis: Fascinating Lesions of the Vermiform Appendix
Laura W. Lamps, M.D.

GIST and Beyond: An Approach to GI Mesenchymal Tumors
John R. Goldblum, M.D.

Practical Considerations of Human Papillomavirus Testing in Head and Neck Squamous Cell Carcinoma
Carmen Gomez-Fernandez, M.D.

Myoepithelial and Combined Epithelial-Myoepithelial Lesions of the Breast
Stuart J. Schnitt, M.D.

Pink Renal Tumors: How Far Can You Go With Morphology
Cristina Magi-Galluzzi, M.D., Ph.D.

Steroidogenic Tumors: Germline Predisposition in Endocrine Neoplasia
Sylvia L. Asa, M.D., Ph.D.

Recent Advances in Bladder Cancer Classification, Grading, Staging and Reporting
Cristina Magi-Galluzzi, M.D., Ph.D.

CME Release Date 08/15/2022